Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine. Issue 27 (8th June 2016)

• Record Type: Journal Article
• Authors: Lundgren, Anna; Jertborn, Marianne; Svennerholm, Ann-Mari
• Is Part Of: Vaccine. Volume 34:Issue 27(2016)
• Page Start: 3132
• Page End: 3140
• Publication Date: 2016-06-08
• Subjects: AE adverse event -- ALS antibodies in lymphocyte supernatants/secretions -- ASC antibody-secreting cell -- BAFF B cell activating factor -- CF colonization factor -- CT cholera toxin -- CTB cholera toxin binding subunit -- dmLT double mutant LT -- ETEC enterotoxigenic Escherichia coli -- GM geometric mean -- LT heat labile toxin -- LTB heat labile toxin binding subunit -- LCTBA CTB/LTB hybrid protein -- LPS lipopolysaccharide -- MEV multivalent ETEC vaccine -- PBMCs peripheral blood mononuclear cells -- PPS per protocol analysis set -- PWM pokeweed mitogen -- SAC Staphylococcus aureus protein A -- SAS safety analysis set -- SIgA secretory IgA -- ST heat stable toxin; ETEC -- Oral vaccine -- Immunological memory -- Mucosal immunity -- IgA; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2016.04.055
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: The capacity of an oral killed ETEC vaccine to induce mucosal IgA memory was tested. The vaccine consisted of a toxoid and E. coli over-expressing colonization factors. The vaccine induced mucosal IgA memory to all major vaccine antigens. The mucosal immunological memory remained ≥1–2 years after priming vaccination. Kinetics of antibody-secreting cell responses can be used to assess immune memory. Abstract: We have evaluated the capacity of an oral multivalent enterotoxigenic Escherichia coli (ETEC) vaccine (MEV) to induce mucosal immunological memory. MEV consists of four inactivated E. coli strains over-expressing the major colonization factors (CFs) CFA/I, CS3, CS5 and CS6 and the LTB-related toxoid LCTB A . Memory responses were analyzed by comparing the magnitudes and kinetics of intestine-derived antibody-secreting cell responses to a single dose of MEV in three groups of adult Swedish volunteers ( n = 16–19 subjects per group) in a Phase I trial: non-immunized controls (I) and subjects who in a previous Phase I trial 13–23 months earlier had received two biweekly doses of MEV (II) or MEV + double mutant LT (dmLT) adjuvant (III). Responses against CFs and LTB were analyzed in antibodies in lymphocyte secretions (ALS) of blood mononuclear cells collected before (day 0) and 4/5 and 7 days after immunization. Specific circulating memory B cells present at the time of the single dose vaccination were also studied to determine if such cells may reflect mucosal memory. Considerably higher and significantly more frequent IgA ALS responses against all CFs and LTB were induced by the single vaccine dose in the previously immunized than in non-immunized volunteers. Furthermore, peak IgA ALS responses against all antigens were observed on days 4/5 in most of the previously immunized subjects whereas only a few previously non-vaccinated individuals responded before day 7. Priming with adjuvant did not influence memory responses. Circulating vaccine specific IgA memory B cells were not detected, whereas anti-toxin IgG memory B cells were identified 13–23 months after priming vaccination. We conclude that MEV induces functional mucosal immunological memory which remains at least 1–2 years. Furthermore, our results support that analysis of antibody-secreting cell responses after booster vaccination may be a useful approach to evaluate longstanding mucosal immunological memory in humans. Clinical trials registration: ISRCTN27096290.